410
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Anti-β2-Glycoprotein I Autoantibody Expression as a Potential Biomarker for Strokes in Patients with Anti-Phospholipid Syndrome

&
Pages 173-177 | Received 07 Nov 2007, Accepted 26 Dec 2007, Published online: 09 Oct 2008

REFERENCES

  • Ali H. Y. M. The Role of Anti-phospholipid Autoantibodies Syndrome in Patients with Cardio-cerebrovascular Diseases. A PhD thesis submitted to College of Medicine, University of Mosul, Iraq 2006
  • Arnout J., Meijer P., Vermylen J. Lupus anti-coagulant testing in Europe: An analysis of results from the First European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human β2-glycoprotein I. Thromb. Haemost. 1999; 81: 929–934
  • Bevers E. M., Galli M., Barbui T., Comfurius P., Zwaal R. F. Lupus anti-coagulant IgG (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb. Haemost. 1991; 66: 629–632
  • Brey R. L., Abbott R. D., Sharp D. S., Ross G. W., Stallworth C. L., Kittner S. J. β 2-Glycoprotein I-dependent anti-cardiolipin antibodies and risk of ischemia stroke and myocardial infarction: The Honolulu heart program. Stroke 2001; 32: 1701–1706
  • Brey R. L., Hart R. G., Sherman D. G., Tegeler C. H. Anti-phospholipid antibodies in cerebral ischemia in young people. Neurology 1990; 40: 1190–1196
  • Brey R. L., Stallworth C. L., McGlasson D. L., Wozniak M. A., Wityk R. J., Stern B. J., Sloan M. A., Sherwin R., Price T. R., Macko R. F., Johnson C. J., Earley C. J., Buchholz D. W., Hebel J. R., Kittner S. J. Anti-phospholipid antibodies and stroke in young women. Stroke 2002; 33: 2396–2400
  • Cabral A. R., Amigo M. C., Cabiedes J., Alarcon-Segovia D. The anti-phospholipid/co-factor syndromes: A primary variant with antibodies to β2-glycoprotein I but no antibodies detectable in standard anti-phospholipid assays. Am. J. Med. 1996; 101: 472–481
  • de Laat H. B., Derksen R. H. W. M., de Groot P. H. β2-Glycoprotein I, the playmaker of the anti-phospholipid syndrome. Clin. Immunol. 2004; 112: 161–168
  • Gatenby P. A. Controversies in the anti-phospholipid syndrome and stroke. Thromb. Res. 2004; 114: 483–488
  • Gharavi A. E., Pierangeli S. S., Colden-Stanfield M., Liu X. W., Espinola R. G., Dracou C. GDKV-induced anti-phospholipid antibodies enhance thrombosis and activate endothelial cells in vivo in vitro. J. Immunol. 1999; 163: 2922–2927
  • Gromnica-Ihle E., Schossler W. Anti-phospholipd syndrome. Int Arch Allergy Immunol. 2000; 123: 67–76
  • Hanly J. G. Antiphospholipid syndrome: An overview. CMAJ. 2003; 24: 168–180
  • Hughes G. R. Hugh's syndrome: The anti-phospholipid syndrome. A historical view. Lupus 1998; 7(S2)s1–4
  • Katsarou E., Attilakos A., Fessatou S., Tsapra H., Tzavara V., Dracou C. Anti-β2-glycoprotein I antibodies and ischemic stroke in a 20-month-old boy. Pediatrics 2003; 112: 188–190
  • Lutters B. C., Meijers J. C., Derksen R. H., Arnout J., de Groot P. G. Dimers of β 2-glycoprotein I mimic the in vitro effects of β2-glycoprotein I-anti-β 2-glycoprotein I antibody complexes. J. Biol. Chem. 2001; 276: 3060–3067
  • Munts A. G., van Genderen P. J., Dippel D. W., van Kooten F., Koudstaal P. J. Coagulation disorders in young adults with acute cerebral ischemia. J. Neurol. 1998; 245: 21–25
  • Nencini P., Baruffi M. C., Abbate R., Massai G., Amaducci L., Inzitari D. Lupus anti-coagulant and anti-cardiolipin antibodies in young adults with cerebral ischemia. Stroke 1992; 23: 189–193
  • Pengo V. (2002) Communication from the 48th Annual SSC Meeting, Boston, MA, July, 182002, http://www.med.unc.edu/isth See annual SSC reports at ISTH website
  • Picillo U., Marcialis M. R., Italiano G. Antibodies to β2-glycoprotein I in anti-cardiolipin-negative patients. J. Rheumatol. 1998; 25: 1440–1442
  • Rampazzo P., Biasiolo A., Garin J., Rosato A., Betterle C., Ruffatti A, Pengo V. Some patients with anti-phospholipid syndrome express hitherto undescribed antibodies to cardiolipin-binding proteins. Thromb. Haemost. 2001; 85: 57–62
  • Roudey R A. Immunology of the anti-phospholipid antibody syndrome. Arthritis Rheum. 1996; 39: 1444–1454
  • Salemink I., Blezer R., Willems G. M., Galli M., Bevers E., Lindhout T. Antibodies to β2-glycoprotein I associated with anti-phospholipid syndrome suppress the inhibitory activity to tissue factor pathway inhibitor. Thromb. Haemost. 2000; 84: 653–656
  • Willems G. M., Janssen M. P., Pelsers M. M., Comfurius P., Galli M., Zwaal R. F., Bevers E. M. Role of divalency in the high-affinity binding of anti-cardiolipin antibody-β 2-glycoprotein I complexes to lipid membranes. Biochemistry 1996; 35: 13833–13842
  • Wilson W. A., Gharavi A. E., Koike T., Lockshin M. D., Branch D. W., Piette J. C., Brey R., Derksen R., Harris E. N., Hughes G. R., Triplett D. A., Khamashta M. A. International consensus statement on preliminary classification criteria for definitive anti-phospholipid syndrome: Report of an international workshop. Arthritis Rheum. 1999; 23: 1309–1311

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.